Emyria Ltd (ASX:EMD) is a Real-World Evidence data company using its network of specialist clinical services and purpose-built, remote patient monitoring technologies and data platforms to accelerate the development and registration of new treatments and facilitate the implementation of valuable new care models.
The healthcare technology and services company is taking a leadership role in digitally-connected and patient-centric healthcare that also generates high-quality clinical evidence where it matters most, in the real world.
